| INTRODUCTION
Primary immunodeficiencies (PID), practically, are a group of 300 rare, chronic disorders characteristically present in childhood with infections that persist with multiple recurrences. T cells are essential for the control of viral and fungal disease. However, they also provide helper function to B cells for antibody responses. Thereby, T-cell disorders present as combined T-and B-cell immunodeficiency with susceptibility to bacterial, viral, and fungal pathogens. 1 In previous years, the diagnosis of certain immunodeficiency diseases could be supported by an absent or decreased proliferation response to mitogenic substances. PID now can be divided as B-cell deficiency, T-cell deficiency, or combined deficiencies by quantification of lymphocyte subsets in peripheral blood by flow cytometry. 2 Flow cytometry studies currently present new insights for assessing T-cell functions. The necessity of detailed measurements of T-cell function such as proliferative ability in response to mitogens accompanied with the use of fluorescent nucleoside analogs that incorporate into the DNA of proliferating cells or fluorescent tracking dyes that are incorporated into the cell. Since 1994, 3 carboxyfluorescein diacetate
The study was approved by the hospital's ethics committee.
succinimidyl ester (CFSE) has been widely used for investigating lymphocyte division and mitotic activity. So, the combination of flow cytometry and T-cell proliferation testing is sufficient to define severe defects in T-cell immunity. These assays involve a mitogen (eg, phytohemagglutinin, PHA) stimulation and a 72-hour culture of both unstimulated and stimulated cells. 6 Proliferation assay based on mitogen stimulation using DNA in- The estimated cumulative prevalence rate for all forms of PID has been documented as 30.5/100 000 in Turkey, and our prevalence rate is 18.8/100 000 in Ege University. 9 Functional studies in PID contrary to routine laboratory methods are not performed in most of the laboratories in our country. Here, we summarize our experience on evalua- forms" were obtained from parents and the study was performed after the approval of local ethics committee.
The following criteria were used to select patients: (i) IgG, IgA, or For in vitro T lymphocyte proliferation testing, we modified CFSE labeling method that was designated by Ouah and Parish. 16 Peripheral 
| RESULTS
A total of 46 patients with mean 64.9±55.2 months of age (min-max:
2-204 months) were included into this study. Twenty-four of them were female (52%) and 22 of them were male (48%).
All demographical and laboratory findings of patient group are summarized in Table 1 . As shown in T lymphocyte proliferation findings in control and patient groups are summarized in Table 2 . As shown in 
2%).
Daughter cell proliferation data of different diagnosis groups are summarized in Table 3 . Neither M % (P=.213) nor PI (P=.387) showed statistically significant difference between IUIS diagnosis groups. The percentages of CD3 did not differ between groups (P=.622).
As shown in Table 3 , the decrease in T-cell proliferative responses was mostly seen for combined immunodeficiency (CID) group. The mean M% was 22.2±22.9 and proliferation index showed an increase from 1.04±0.03 to 1.33±0.42 with stimulation in these patients. Six of eighteen CID patients had low values for CD3%. Neither M% nor PI after stimulation had relation to CD3 low or normal percentages (P=1.000). Sixteen of CID patients (n=18) had impaired proliferative response and seven of them had low M% values below 5%.
| DISCUSSION
As highlighted in our previous studies, 17, 18 high prevalence of PID is seen due to high percentage of consanguineous marriages in Turkey.
Twenty patients (43.5%) were born to consanguineous parents, and family history of PID was positive for twelve patients (26.1%) in this study.
Primary immunodeficiencies are a group of chronic disorders that present in childhood and T-cell disorders present as combined T-and B-cell immunodeficiency with susceptibility to bacterial, viral, and fungal pathogens. 1 A total of 70.5% of our patients had infections on admission. The sinopulmonary infections were the most frequent type similar to literature 17, 19, 20 , and a total of 54.3% of patients had mini- antigenic T-cell proliferation responses provides us to diagnose and classify T-cell defects according to IUIS. 10 This assay also gives an idea for both cell function and viability more effectively as opposed to radioactive assays such as thymidine uptake assays. These cumbersome radioisotope-based assays are replaced with CFSE method as later one is less labor-intensive, cheaper to perform, is able to focus analysis on particular lymphocyte subsets and is able to measure expression of activation markers directly and in terms of cell cycle. 21 Evrard et al. 4 suggested that thymidine test was not sufficiently accurate and CFSE method using an apoptosis marker together would yield more information about targeted lymphocytic proliferation in quality control of extracorporeal photopheresis. Similarly, Faivre et al. 22 emphasized the CFSE method's benefits besides reference thymidine method in this practice.
Decreased mean values for immunoglobulins (45.7%, 53.3%, and 41.3% of patients for IgG, IgA, and IgM) were expected findings in our patients and changes in T-and B-cell percentages, naive and memory T-cell pool or T lymphocyte cell receptor profile also helped us for definitive diagnosis. On the other hand, in vitro T-cell proliferation responses especially in patients with normal T-cell counts gave us an idea for detecting prior exposure of T cells to antigens.
Lymphocyte proliferation response to mitogens may be affected by the use of steroids, immunosuppressive or immunomodulatory agents, alcohol, physiological-social stress, and the time elapsed since blood collection. These were taken into consideration during evaluation of our patients' data for these factors and collected all samples on the day of study. Samples were diluted in the presence of excess neutrophils or nonviable cells to avoid falsely diminished results.
T T-cell proliferation response is a functional marker of effective immune response and the degree of impairment may vary depending on T-cell capability. CD3 + T-cell proliferation responses, both M% and proliferation indexes that are recorded in patient group, were lower than controls after stimulation ( 
